Brief: Shilpa Medicare Says Europe Approval For Varenicline Tablets, 0.5 Mg And 1mg
26/02/2024 05:32
Feb 26 (Reuters) - Shilpa Medicare Ltd SHME.NS :
* RECEIVED CLOSURE OF DECENTRALIZED PROCEDURE FOR
VARENICLINE
TABLETS, 0.5 MG AND 1 MG
* COMMERCIAL SUPPLIES SHALL BE STARTED AFTER APPROVAL OF
NATIONAL
PROCEDURE
* EUROPE APPROVAL FOR VARENICLINE TABLETS, 0.5 MG AND 1MG
Source text for Eikon: ID:nBSE6xKLYh
Further company coverage: SHME.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026